Kite Pharma (KITE) Posts Q4 Loss of 85c/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Kite Pharma (KITE) Posts Q4 Loss of 85c/Share

Jefferies Reiterates Buy on Kite Pharma (KITE) Following a Mixed 4Q - PT to $75

March 1, 2016 9:31 AM EST

Jefferies maintained a Buy rating on Kite Pharma (NASDAQ: KITE), and cut the price target to $75.00 (from $92.00), following the company's 4Q earnings conference call. KITE reported Q4 revenues of $4.9M, coming in ahead of Jefferies' estimate of $4.4M. GAAP EPS of ($0.85) also beat estimates... More

Citi Starts Kite Pharma (KITE) at Buy

February 25, 2016 8:25 AM EST

Citi initiatesd coverage on Kite Pharma (NASDAQ: KITE) with a Buy rating and a price target of $67.00.

For an analyst ratings summary and ratings history on Kite Pharma click here. For more ratings news on Kite Pharma click here.

Shares of Kite Pharma closed at $44.97 yesterday.

... More